S. African COVID-19 variant better at bypassing Pfizer/BioNTech jab - Study
The Israeli study was the first real-world assessment of the South African variant's ability to bypass a vaccine.
Tue Apr 13 2021
Israeli study finds 94 pct drop in symptomatic COVID-19 cases with Pfizer vaccine
Clalit reported a 94 pct drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine.
Tue Feb 16 2021